Supra-molecular assembly of a lumican-derived peptide amphiphile enhances its collagen-stimulating activity by Walter MNM et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work is licensed under a Creative Commons Attribution 3.0 Unported License 
 
 
Newcastle University ePrints - eprint.ncl.ac.uk 
 
Walter MNM, Dehsorkhi A, Hamley IW, Connon CJ. Supra-molecular 
assembly of a lumican-derived peptide amphiphile enhances its collagen-
stimulating activity. Biomaterials Science 2015, DOI: 10.1039/C5BM00428D 
 
 
Copyright: 
This journal is © The Royal Society of Chemistry 2015. This article is licensed under a Creative 
Commons Attribution 3.0 Unported Licence.  
DOI link to article: 
http://dx.doi.org/10.1039/C5BM00428D  
Date deposited:   
02/12/2015 
  
Biomaterials
Science
PAPER
Cite this: DOI: 10.1039/c5bm00428d
Received 1st October 2015,
Accepted 20th November 2015
DOI: 10.1039/c5bm00428d
www.rsc.org/biomaterialsscience
Supra-molecular assembly of a lumican-derived
peptide amphiphile enhances its collagen-
stimulating activity†
Merlin N. M. Walter,a Ashkan Dehsorkhi,b Ian W. Hamleyb and Che J. Connon*a
C16-YEALRVANEVTLN, a peptide amphiphile (PA) incorporating a biologically active amino acid sequence
found in lumican, has been examined for its influence upon collagen synthesis by human corneal fibro-
blasts in vitro, and the roles of supra-molecular assembly and activin receptor-like kinase ALK receptor
signaling in this effect were assessed. Cell viability was monitored using the Alamar blue assay, and col-
lagen synthesis was assessed using Sirius red. The role of ALK signaling was studied by receptor inhibition.
Cultured human corneal fibroblasts synthesized significantly greater amounts of collagen in the presence
of the PA over both 7-day and 21-day periods. The aggregation of the PA to form nanotapes resulted in a
notable enhancement in this activity, with an approximately two-fold increase in collagen production per
cell. This increase was reduced by the addition of an ALK inhibitor. The data presented reveal a stimulatory
effect upon collagen synthesis by the primary cells of the corneal stroma, and demonstrate a direct
influence of supra-molecular assembly of the PA upon the cellular response observed. The effects of PA
upon fibroblasts were dependent upon ALK receptor function. These findings elucidate the role of self-
assembled nanostructures in the biological activity of peptide amphiphiles, and support the potential use
of a self-assembling lumican derived PA as a novel biomaterial, intended to promote collagen deposition
for wound repair and tissue engineering purposes.
Introduction
Damage to the cornea, whether occurring through mechanical
or chemical insult or as a result of hereditary or infectious
disease, can result in reduced transparency and potential
blindness. Corneal transplantation is the most common
method of treatment once injury or disease has affected the
clarity of the cornea, and whilst this is the most successful
solid organ transplant performed, it is limited by its depen-
dence upon the availability of suitable donor tissue.1 As a
result of this, a large body of research has been focused on the
engineering of corneal tissue suitable for therapeutic trans-
plantation. Tissue engineering methods often seek to combine
cells with a suitable scaffold to replicate native tissue. In
addition to the synthetic scaffold materials and de-cellularised
donor tissues commonly investigated for this purpose, recently
there has been increased interest in the use of cells cultured
in vitro to produce a native-like extracellular matrix (ECM) for
subsequent seeding with tissue-specific cell types to poten-
tially produce ‘organotypic’ engineered tissues. We, and
others, have recently developed methods of culturing corneal
stromal fibroblasts on synthetic substrates that inform or
otherwise facilitate the production of collagenous lamellae
intended to replicate corneal stroma.2,3 These techniques are
dependent upon the in vitro synthesis of collagen by cells and
could therefore benefit from factors that enhance or mediate
this process. Additionally the healing of corneal wounds and
conditions associated with pathological matrix degradation,
such as keratoconus or chronic stromal ulceration, might
benefit from the topical application of a bioactive molecule
capable of stimulating collagen production by the endogenous
cell population.
Peptide amphiphiles are ‘a class of molecules that combine
the structural features of amphiphilic surfactants with the
functions of bioactive peptides and are known to assemble
into a variety of nanostructures’,4 comprised of a hydrophobic
‘tail’ region and a hydrophilic peptide ‘head’. These molecules
have demonstrated potential for a range of biomedical
applications, either via their amphiphilicity and resultant
compatibility with the lipid bilayer of cell membranes, capacity
to present functional peptides in high densities upon the
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surface of supra-molecular assemblies, or suitability to form
bioactive or cell-responsive ‘smart’ biomaterials,3,5,6 or a
combination of these factors. Previously, a PA (C16-KTTKS)
frequently used in commercially available skincare cosmetics,
under the trade name Matrixyl™, was shown to stimulate the
production of collagen by fibroblasts in vitro.7 Matrixyl is a
lipidated peptide based upon a KTTKS pentapeptide head
sequence, derived from a human type-1 collagen propeptide
attached to a palmitic acid (C16) hexadecyl lipid chain.
8,9 In this
study we have investigated the effects of a PA based upon a 13-
residue sequence, YEALRVANEVTLN, derived from the C-termi-
nus of the small leucine rich proteoglycan lumican, also
attached to a C16 hydrophobic tail (Fig. 1). In particular we
focused on the enhanced bioactivity of the PA in
supra-molecular form and its specific mode of action. Whilst
there have been numerous publications studying the bioactivity
of various PA’s none, to the authors knowledge, have directly
compared this activity of a PA in aggregated and unaggregated
forms at the same concentration.
Lumican, along with keratocan and mimecan, is a major
keratan sulphate proteoglycan found in the ECM of many col-
lagenous tissues including skin, tendons, cartilage, and the
corneal stroma.10–12 More specifically, in the cornea, lumican
has been shown to be essential for the maintenance of corneal
transparency10,13 by influencing epithelial and stromal cell
behaviors though matrikine function i.e. stimulating corneal
epithelial wound healing14 and regulating collagen fibrillo-
genesis.15,16 A recent study by Yamanaka and co-workers
demonstrated the binding of lumican to the TGF-β superfamily
type I activin receptor-like kinase, ALK5, by its C-terminal
domain; an approximately 50 amino acid sequence. Within
this sequence, a 13-residue peptide (YEALRVANEVTLN)
capable of stimulating epithelial migration17 was identified.
This work, as well as the collagen stimulating effects of
another ECM-derived peptide sequence based PA (Matrixyl™),
and the well-documented role of TGF-β signaling pathways in
ECM synthesis and fibrotic response,18 has informed the
current investigation. The peptide amphiphile C16-YEALRVA-
NEVTLN, incorporating a biologically active amino acid
sequence found in lumican, has been examined for its effects
upon human corneal fibroblasts in vitro, and the contribution
both of supra-molecular assembly and ALK signaling in these
effects have been investigated.
Materials and methods
Materials
The C16-YEALRVANEVTLN PA was purchased from CS Bio (Cali-
fornia, USA). Purity was 95.68%. The molar mass was 1730.89
Da (expected 1730.05 Da).
Formation of monomeric and aggregated PA solutions
The PA was dissolved by ultra-sonication at 55 °C in ultra-pure
water to concentrations either below (0.025 wt%) or above
(0.1 wt%) the published critical aggregation concentration
(CAC) 0.03 wt%, the point at which the PA self-assembles into
a highly ordered twisted nanotape structure.19 At this point the
PA exists as either a solution of monomeric molecules (in
those samples made at 0.025 wt%) or as a solution of aggre-
gated PA nanotapes (in those samples made at 0.1 wt%). These
stock solutions (in monomeric or aggregated form; below or
above the CAC) were each subsequently diluted in ultra-pure
H2O to make 0.00125 wt% and 0.0025 wt% experimental solu-
tions of PA, resulting in working solutions of equally concen-
trated but differently arranged PA molecules at each
concentration, in order to compare the effects of supra-mole-
cular assembly upon the cellular responses in vitro. Thus the
supramolecular self-assembly of the PA at concentrations
above its CAC is crucially maintained upon its subsequent
dilution as aggregates formed above the CAC are kinetically
trapped.
Cell culture
Human corneal fibroblasts were isolated from corneal rings
from post-mortem human donor eyes following depletion of
epithelial cells. Corneal tissue was finely minced using a
scalpel and subsequently digested in 2 mg ml−1 collagenase
type-I (Invitrogen, USA) in Dulbecco’s Modified Eagles
Medium (DMEM) supplemented 5% fetal bovine serum (FBS)
for 5 hours under gentle rotation (15 rpm) at 37 °C/5% CO2.
Isolated cells were plated onto standard culture plates
(Corning, USA) and maintained in DMEM/F12 media (Invitro-
gen) supplemented with 5% FBS, 1 mM ascorbic acid, and 1%
penicillin/ streptomycin. The cells were routinely passaged at
70%–80% confluence and used experimentally between
passage numbers 2–4. Culture medium was replaced with
serum-free media (SFM) supplemented with 1% ITS (insulin,
Fig. 1 C16-YEALRVANEVTLN PA is comprised of a 13 amino acid sequence (Tyr-Glu-Ala-Leu-Arg-Val-Ala-Asn-Glu-Val-Thr-Leu-Asn) and a hexa-
decyl (C16) lipid chain.
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transferrin and selenium) (Invitrogen) three days prior to sub-
sequent experiments in order to induce cells to adopt a kerato-
cyte-like phenotype.
Circular dichroism spectroscopy
Circular dichroism was performed according to previously
published methods20 using a Chirascan spectropolarimeter
(Applied Photophysics, UK). Spectra are presented with absor-
bance A < 2 at any measured point with a 0.5 nm step, 1 nm
bandwidth, and 1 second collection time per step at 20 °C.
Post-acquisition smoothing was used to remove random noise.
Cell viability
The tolerance of human corneal fibroblasts to C16-YEALRVA-
NEVTLN was determined using the Alamar blue assay, which
correlates cellular metabolism to the reduction of a resazurin
sodium salt (Sigma-Aldrich, Dorset, UK) by mitochondrial
dehydrogenase activity. Fibroblastic cells, 1 × 104 per well, were
seeded (serum free) into 24 well plates (Corning) and allowed
to adhere overnight before exposure to 0.00125 wt% and
0.0025 wt% solutions of PA (either in monomeric or aggre-
gated form prior to dilution) in SFM. Cultures were main-
tained for seven days or three weeks. PA-supplemented and
un-supplemented (control) growth media were replaced every
two days over the culture periods. At the end of these culture
periods media were replaced with resazurin reagent (1 : 10 in
SFM) and incubated for 3 hours (37 °C/5% CO2) at which point
100 μl samples were taken in duplicate from each well and
assayed for fluorescence emission at 590 nm under excitation
at 544 nm using a Fluoroskan Ascent™ (Thermo scientific,
Paisley, UK). The cell number was calculated by interpolation
using a standard curve for the fluorescence values derived
from known numbers of cells, determined in parallel with
each separate assay. The PA solutions had no effect, in either
monomeric or diluted aggregate form, upon the reduction of
resazurin in the absence of cells.
Collagen synthesis
The amounts of collagen produced by fibroblasts in response
to the aforementioned concentrations of C16-YEALRVANEVTLN
in momomeric or diluted aggregated form were assessed by
the Sirius red assay. Following the evaluation of viable cell
number by Alamar blue, seven day and three week fibroblast-
cultures were fixed in ice-cold ethanol for 10 minutes at −80 °
C and stained with 1 mg ml−1 Sirius-red/picric acid solution
overnight. These wells were then repeatedly rinsed in phos-
phate buffered saline (PBS) and the bound dye was recovered
after 15 minutes of agitation in 1 M NaOH. Total collagen
content was calculated by comparing the absorbance of the
resulting samples at 490 nm, read using a Multiskan Ascent™
spectrometer (Thermo scientific), to that of known standard
concentrations of collagen (First Link, Wolverhampton, UK).
ALK receptor inhibition
Sirius red assays were also performed upon cells treated with
PA in the presence of an ALK inhibitor, SB 431542 (Sigma-
Aldrich) at 0.5 μM in dimethyl sulfoxide (DMSO), compared to
media supplemented with DMSO alone (vehicle only).
Image capture and analysis
Digital images were captured using an Eclipse TS100 inverted
microscope (Nikon, Surrey, UK) and a ProgRes speed XT core-5
digital camera (Jenoptik, Jena Germany).
Statistical analysis
Data is presented as means of n = 3 independent experiments
performed using cells from different donor corneas (±SEM)
where each individual experimental value is the mean of n = 4
internal replicates. Data were tested for significance using a
non-parametric ANOVA appropriate for non-normally distribu-
ted data21 and post-hoc analysis was performed using Tukey’s
HSD test.22 Those differences that fell within a 95% confidence
interval were considered to be significant, indicated by aster-
isks within figures (*p < 0.05).
Results
Spectroscopic methods were used to examine the secondary
structure of the PA following its aqueous dilution from a
sufficiently concentrated form (0.1 wt%) that results in the
spontaneous self-assembly of bi-layered nanotape structures
(Fig. 2a). Fig. 2b shows circular dichroism (CD) spectra for a
0.0025 wt% aqueous solution of PA either (i) initially made to
0.1 wt% (i.e. above its published CAC) and subsequently
diluted to 0.0025 wt% henceforth referred to as diluted-aggre-
gated (black) or (ii) made directly to 0.0025 wt% henceforth
referred to as monomeric (red). The CD spectrum for (i) reveals
a minimum at 216 nm and a maximum at 195 nm, character-
istic of β-sheet secondary structure, that is not present in the
spectra for (ii). This indicates the retention of secondary struc-
tures upon subsequent dilution of aggregated PA, and the
absence of such in directly prepared (monomeric) solutions at
0.0025 wt%. Fig. 3a shows the CD spectrum for a 0.0025 wt%
aqueous solution of PA diluted from an initial concentration of
0.1 wt% (aggregated form) and maintained over 6 days at room
temperature. These spectra demonstrate that the secondary
structure (initially formed by dissolving the PA above its CAC)
persists for this period with no apparent degradation over time
despite its subsequent dilution. Solutions of PA directly pre-
pared to 0.0025 wt% (below the CAC) continue to display an
absence of secondary structure throughout this period (Fig. 3b).
Human corneal fibroblasts cultured in 0.0025 wt% and
0.00125 wt% PA solutions showed the normal fibroblastic mor-
phology expected for cells in 2D culture (Fig. 4) and displayed
good, though reduced, viability after seven days exposure to
both monomeric (blue) and diluted-aggregated (green) PA as
assessed by the Alamar blue assay (Fig. 5 and 6). Notably,
0.00125 wt% PA solutions resulted in viable cell numbers that
were not significantly different to those cultures maintained in
SFM alone for both monomeric and diluted-aggregated PA
forms (Fig. 5 and 6 respectively). Higher concentrations of PA
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were less well tolerated; solutions of 0.01 wt% and 0.005 wt%
both caused a loss of over 30% of cells compared to control
(no PA) after only 72 hours in culture (ESI Fig. 1†).
Over seven days in culture, human corneal fibroblasts pro-
duced significantly greater total amounts of collagen both in
monomeric and diluted-aggregated solutions of PA, at both
0.00125 wt% and 0.0025 wt% concentrations, where those
cells in solutions of monomeric PA produced 6.7 μg (±0.2 μg)
7.4 μg (±0.8 μg) respectively, compared to 3.6 μg (±0.1 μg) in
SFM alone (Fig. 5). Similarly, fibroblasts cultured in diluted-
aggregated PA produced 7.8 μg (±0.2 μg) and 7.7 μg (±0.2 μg) of
collagen respectively, compared to 4.4 μg (±0.2 μg) in SFM
alone (Fig. 6). As the number of cells in each culture would
undoubtedly influence the overall amounts of collagen
synthesised, the total mass of collagen was normalized to
viable cell number as determined by the alamar blue assay,
revealing an approximately two-fold increase in collagen
production per cell between fibroblasts in 0.00125 wt% PA and
those cultured in SFM alone, in both monomeric PA (Fig. 5)
and diluted-aggregated PA (Fig. 6) solutions, with a further,
albeit less pronounced, increase in collagen per cell in
0.0025 wt% solutions compared to those at 0.00125 wt%.
Over an extended period of culture (21 days), human
corneal fibroblasts cultured in PA solutions maintained good
viability, where the least tolerated condition (0.00125 wt%
diluted-aggregated PA) nevertheless retained >70% of the
viable cell number observed in SFM controls. Fibroblasts in
monomeric PA solutions showed improved viability compared
to that observed over seven days, relative to controls. Cell
numbers were not significantly different in the presence of
0.0025 wt% PA compared to 0.00125 wt% PA in either mono-
meric or diluted-aggregated PA solutions (Fig. 7). When
Fig. 2 Cryo-TEM shows that aqueous solutions of C16-YEALRVANEVTLN PA form bi-layered nanotapes structures at 0.1 wt% concentrations (a).
These secondary structures are maintained upon subsequent dilution to a biocompatible concentration of 0.0025 wt% (b) demonstrated by the
minimum at 216 nm and the maximum at 195 nm typical of beta-sheet formations (black). These features are absent in spectra obtained from PA
solutions initially prepared at 0.0025 wt% (red).
Fig. 3 The secondary structure of C16-YEALRVANEVTLN PA is observable in solution for up to 6 days following dilution to 0.0025 wt%, as shown by
circular dichroism spectroscopy, with no signs of degradation correlating to time in culture (a). At initial concentrations of 0.0025 wt%, aqueous
solutions of C16-YEALRVANEVTLN PA do not display signs of secondary structure (b).
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directly compared over 21 days, values for both total mass of
collagen produced and collagen per cell were shown to be
significantly greater in response to diluted-aggregated PA solu-
tions than monomeric PA at the same wt% (Fig. 7).
Fibroblasts treated with diluted-aggregated PA at these
efficacious concentrations in the presence of the ALK receptor
inhibitor (+SB 431542) were unresponsive to the PA, failing to
synthesize more collagen over 7 days than those cells cultured
Fig. 4 Fibroblasts tolerate PA concentrations of 0.00125 wt% and 0.0025 wt% and maintain normal morphology over 7 days in PA supplemented
cultures.
Fig. 5 Viability and collagen synthesis by human corneal fibroblasts after culture for seven days in monomeric-PA supplemented SFM.
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without PA (no significant differences were observed between PA-
treated and zero PA-treated control cultures), whereas those cells
treated with the PA in the presence of the DMSO diluent only
(−SB 431542) maintained their ability to produce significantly
more collagen than the zero PA-treated control cultures (Fig. 8).
Discussion
A peptide amphiphile (PA) has been designed based upon a
biologically active peptide sequence derived from the C-termi-
nal domain of lumican. This PA has been shown to self-
assemble at 0.03 wt% to form bi-layered tape-like structures,19
however here we demonstrate that the beta sheet structures are
maintained upon subsequent dilution to efficacious and bio-
compatible concentrations and importantly are stable over
time in aqueous solution, suggesting that PA-aggregates
formed at high concentration are kinetically trapped, resulting
in no re-establishment of the monomeric state upon dilution.
We believe such an observation has not previously been
reported. This gives further credence to the application of PAs
as a potential new class of bioactive molecule.
Fig. 6 Viability and collagen synthesis by human corneal fibroblasts after culture for seven days in diluted-aggregated PA supplemented SFM.
Fig. 7 Viability and collagen synthesis by human corneal fibroblasts after culture for twenty-one days in monomeric PA and diluted-aggregated PA
supplemented SFM.
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Low concentrations of PA in either monomeric or diluted-
aggregated form are shown to be well tolerated by corneal
fibroblasts in culture and C16-YEALRVANEVTLN strongly
stimulates the synthesis of collagen. Of particular note, this
enhancement is significantly greater in the case of the diluted-
aggregated PA, suggesting a role of the secondary structure of
this molecule in its biological activity. This was particularly
apparent when the two conditions were directly compared over
21 days as shown in Fig. 7. It is worth noting that no similar
direct comparison of the effects of monomeric and diluted-
aggregated PA can be made from the differences shown
between Fig. 5 and 6, as these experiments were run indepen-
dently of each other using potentially variable primary cells
derived from different sets of (n = 3) donor corneas. This
variability may account for the observable difference in the
negative controls in each of Fig. 5 and 6, which are otherwise
identical conditions. The effect of C16-YEALRVANEVTLN on
corneal fibroblasts was abrogated in response to the inhibition
of ALK receptors, a known lumican binding site.17
As previously stated, the maintenance of the collagenous
matrix of the corneal stroma by fibroblasts is essential to
corneal transparency, and by extension to the function of the
entire eye. Similarly the deposition of collagen by fibroblasts
in vitro is of interest as a potential method for the production of
native like tissue for the engineering of ‘organotypic’ cornea to
eventually reduce or remove the demand for donor tissue. We
have previously demonstrated the ability of cultured fibroblasts
to synthesize a collagenous membrane with distinct simi-
larities to stromal lamellae, and that can be recovered from
culture, handled with relative ease, showing excellent potential
for further investigation as a scaffold for the tissue engineering
of an artificial corneal stroma.3 Tissue engineering processes
such as this or the direct repair of diseased corneas via topical
application, would likely benefit from an enhancement of
extracellular matrix secretion by resident stromal fibroblasts.
The peptide amphiphile C16-YEALRVANEVTLN showed good
cyto-compatibility, as concentrations sufficient to induce a
marked enrichment in collagen synthesis demonstrated little
or no reduction in cell number, whilst higher concentrations
capable of further enhancing collagen production still main-
tained cell numbers greater than 70% of those in standard
medium. This compares favorably with Matrixyl™, a PA
approved for commercial use in cosmetics for skin care. In
similar conditions, Matrixyl™ was shown to reduce the
number of viable fibroblasts by 70% or more.7 In terms of col-
lagen production C16-YEALRVANEVTLN displays effects similar
to those of Matrixyl™ on both corneal fibroblasts as shown
here, and on dermal fibroblasts19 in vitro, but with seemingly
less pronounced effects upon cell viability. Thus, as it is pre-
sumed that the effect of Matrixyl™ upon facial wrinkles7,23 is
due to its collagen stimulating activity, C16-YEALRVANEVTLN
may be equally or better suited to the commercial niche in
skincare applications currently occupied by C16-KTTKS.
In addition to the observed effects of C16-YEALRVANEVTLN
in solution, PAs have previously been used as coatings for
culture surfaces or as scaffolds to mediate or instruct cell be-
havior.3,5 The PA investigated here may make a suitable
addition to such systems, either individually to stimulate the
production of collagen by cells for tissue engineering pur-
poses, or as part of a multi-molecular system wherein a range
of bioactive peptide motifs are presented in controlled ratios
within the same supra-molecular structure. We have previously
used a bi-molecular system incorporating RGDS presenting
peptides along with a PA containing an inactive ‘spacer’
peptide head (ETTES)3,5 to reduce the amount of RGDS groups
per unit area. The native ECM is formed of numerous fibrillar
proteins, proteoglycans/glycosaminoglycans, and other mole-
cules, each displaying a variety of motifs that are recognizable
by cell surface receptors. The orientation and relative abun-
dance of these motifs contribute to cellular recognition of the
microenvironment and instruct cell behavior accordingly. It
seems feasible, then, that PA superstructures that can present a
range of precisely spaced and concentrated peptide motifs
might be developed to mimic the instructional and regulatory
properties of native tissue and thus perhaps reproduce in vivo
niche conditions in in vitro culture systems and upon the
surface of synthetic biomaterials. In this respect there is cer-
tainly a strong rationale to investigate the self-assembly and
bioactivity and their inter-relationship of PAs containing bio-
derived peptide sequences, as has been performed in this study.
These data support the potential of peptide amphiphiles
for use as a novel class of bioactive molecules, in this instance
for the support of tissue regeneration through stimulating the
synthesis of the collagenous extracellular matrix. The in vivo
repair of corneal injury extending beyond the epithelia into the
stromal tissue requires the synthesis of new matrix material to
replaced damaged tissue. This is dependent upon the acti-
vation of the quiescent fibroblast population. Within 6 hours
of injurious insult, fibroblasts enter into the cell cycle,
increase their organelle content and migrate towards the site
of injury adopting a more fibroblastic phenotype.24 These cells
Fig. 8 ALK receptor inhibition reduced the bioactivity of C16-YEALRVA-
NEVTLN. Human corneal fibroblasts failed to respond to PA treatment in
the presence of an ALK inhibitor (+SB 431542) compared to a significant
response to PA treatment when exposed to the DMSO diluent alone
(−SB 431542).
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then synthesise new extracellular matrix proteins and, over
time, model the newly secreted matrix to reconstitute functional
corneal tissue.25 Although responsive to stimulatory factors
secreted by platelets, the avascular nature of corneal tissue
means that many of the cues for this transition are provided by
the cells of the corneal epithelium, and its basement mem-
brane.26 This outside-in (i.e. from the external epithelial side of
the tissue rather than internal vasculature) instruction of the
fibroblast response to injury supports a potential role for topical
application of factors that mediate the behaviour of fibroblasts.
The ability to stimulate the production of extracellular matrix
proteins, such as the collagens that form the bulk of this tissue,
by the endogenous cell population may have potential in the
treatment of diseases such as persistent corneal stromal ulcera-
tions, and keratoconus, both sight threatening conditions
characterised, in part, by ECM degradation.27,28
TGF-β is a common ligand against ALK receptors and its
addition to cells in vitro has been shown to enhance the syn-
thesis of collagen29,30 Similarly, lumican has been previously
shown to be complementary to ALK receptors17 inducing
receptor dimerization and activation of the SMAD dependent
signaling pathway that can result in up-regulation of collagen
synthesis.31 Thus it seemed probable that the peptide ‘head’ of
the C16-YEALRVANEVTLN molecule would also interact with
this pathway. Indeed, the effects of the PA upon collagen syn-
thesis were considerably abrogated in the presence of the ALK
receptor inhibitor (indicated by the loss of the statistically sig-
nificant response observed in the absence of exogenous ALK
inhibition) giving a nascent mechanistic insight into the bio-
logical action of this PA. Future studies could confirm these
results using corneal fibroblasts from SMAD knockout mice.32
Interestingly the significance of the diluted-aggregated
form of C16-YEALRVANEVTLN on collagen production may be
dependent upon the enhanced activation of ALK receptors.
The retained supra-molecular structure of the diluted-aggre-
gated PA has the unique capacity to present a highly concen-
trated amount of the bio-active peptide to the cells. Dense
peptides along the surface of the nanotape could lead to a
localized concentration (many times higher than the overall
concentration of PA in solution) at the cell surface. As such
these regions of high ligand density could aid in the assem-
bling and clustering of the ALK receptors resulting in a focal
point for SMAD phosphorylation (Fig. 9). Achieving such a
‘critical mass’ of localized signaling may not be so readily
achieved when using the same wt% PA solution in its mono-
meric form (as indeed our data suggests).
In summary, a peptide amphiphile has been designed
based upon a biologically active peptide derived from the
C-terminal domain of lumican. This PA self assembles at
0.1 wt% to form bilayered tape-like structures that are stable in
aqueous solution and maintained upon subsequent dilution,
is biocompatible at efficacious concentrations, and stimulates
collagen synthesis by corneal fibroblasts. This stimulatory
effect is enhanced by aggregation of PA into supra-molecular
structures and the biological effects of this nanotape form may
be mediated by ALK receptor activity. As such these findings
demonstrate the cyto-compatibility and bioactivity of C16-
YEALRVANEVTLN, reveal the influence of supra-molecular
assembly and, overall, support the potential use of a self-
assembling lumican-derived PA as a novel biomaterial,
intended to promote collagen deposition for wound repair and
tissue engineering purposes.
Fig. 9 Possible localization of ALK receptors to PA nanotapes: Diluted-aggregated PA (a) presents a high regional concentration of a bioactive
sequence (e.g. YEALRVANEVTLN) capable of binding to a transmembrane receptor (e.g. ALK) potentially resulting in a localized increase (b) in the
activation of signal transducing proteins (SMAD2, SMAD4) and potentially greater downstream signalling, when compared to an equal concentration
of monomeric PA solution, wherein the active sequence is presented to the cell surface in a more disperse fashion (c) leading to a less localized acti-
vation of signalling proteins (d) and thus comparatively lesser downstream signalling.
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Abbreviations
ALK Activin receptor-like kinase
ANOVA Analysis of variance
CAC Critical aggregation concentration
CD Circular dichroism
DMEM Dulbecco’s modified eagle’s medium
DMSO Dimethyl sulfoxide
ECM Extracellular matrix
FBS Fetal bovine serum
HSD Honest significant difference
ITS Insulin, Transferrin and Selenium
PA Peptide amphiphile
SEM Standard error of the mean
SFM Serum-free media
TGF-β Transforming growth factor-beta
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